Emergence of Influenza A(H7N4) Virus, Cambodia.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 17 7 2019
medline: 15 7 2020
entrez: 17 7 2019
Statut: ppublish

Résumé

Active surveillance in high-risk sites in Cambodia has identified multiple low-pathogenicity influenza A(H7) viruses, mainly in ducks. None fall within the A/Anhui/1/2013(H7N9) lineage; however, some A(H7) viruses from 2018 show temporal and phylogenetic similarity to the H7N4 virus that caused a nonfatal infection in Jiangsu Province, China, in December 2017.

Identifiants

pubmed: 31310233
doi: 10.3201/eid2510.190506
pmc: PMC6759271
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1988-1991

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400006C
Pays : United States

Références

J Infect. 2018 Sep;77(3):249-257
pubmed: 30017611
Epidemiol Infect. 2014 May;142(5):896-920
pubmed: 24423384
J Infect. 2018 Sep;77(3):249-257
pubmed: 29898409
Emerg Microbes Infect. 2019;8(1):637-639
pubmed: 30999819
Virology. 2018 Oct;523:22-26
pubmed: 30075357
Emerg Infect Dis. 2018 Jun;24(6):1103-1107
pubmed: 29774842
Vaccine. 2009 Oct 23;27(45):6345-52
pubmed: 19840671
Emerg Microbes Infect. 2016 Jul 20;5(7):e70
pubmed: 27436362

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH